By Julie Steenhuysen CHICAGO (Reuters) - Reports of two patients who found relief from long COVID after taking Pfizer Inc's antiviral Paxlovid, includ.
Reports of two patients who found relief from long COVID after taking Pfizer s antiviral Paxlovid, including a researcher who tested it on herself, provide intriguing evidence for clinical trials to help those suffering from the debilitating condition, experts and advocates say.